drugset / Trial / NCT00381589

Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide

NCT00381589

RandomizedCrossoverDouble-blindTreatment

Summary

Hypersalivation (Too much saliva) and drooling is a side effect experienced by 31% of people taking the antipsychotic clozapine. This study aims to determine if using the medication ipratropium bromide(IPB)at bedtime will reduce the amount of salivation and the distress people may feel.

Timeline

Start
2006-10
Primary completion
2008-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule 0.03 % Other

Indications

No indication recorded.